- call +1-201-465-4211
- email sales@mrinsights.biz
Gastroesophageal reflux disease involves the backflow of stomach’s content to mouth through esophagus which gives a burning sensation behind breast bone. Gastroesophageal reflux disease is a common digestive disorder which affects the food pipe and lower esophageal sphincter by deteriorating its elasticity. Gastroesophageal reflux disease occurs due to lifestyle changes and irregular eating habits & over consumption of fatty foods, coffee, alcoholic beverages, citrus fruits and pepper. In Gastroesophageal reflux disease there is excessive production of acid which damages the stomach lining and ultimately cause ulcers. Gastroesophageal reflux disease includes other symptoms such as regurgitation and dysphagia. However, abnormal reflux may cause uncharacteristic symptoms such as coughing, sore throat, otitis media, chest pain and enamel erosion or other dental manifestations.
Scope of the Report:
This report focuses on the GERD in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The overall market has been experiencing a downturn in terms of revenue in the past several years as the leading drugs for GERD treatment have lost their patent protection, with their market shares now largely consumed by over-the-counter (OTC) and generic medications. Although loss of exclusivity of high-grossing drugs have caused a market fall-off, the demand for acid reducing drugs due to the high prevalence and incidence levels of GERD will prove beneficial to the industry from a commercial standpoint. GERD is one of the commonly observed recurrent gastrointestinal disorders worldwide. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives, but also extends to the healthcare system and economy.
The Americas will be the highest revenue generating market segment during the forecast period. The high incidence of GERD in this region will lead to the increase in consumption of various drugs meant to treat the patients.
The worldwide market for GERD is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
AstraZeneca
Eisai
GlaxoSmithKline
Johnson & Johnson
Takeda
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Proton Pumps Inhibitors
H2 Receptor Antagonists
Antacids
Prokinetics
CAM
Market Segment by Applications, can be divided into
Hospital Pharmacy
Drug Stores
General Stores
Supermarkets
There are 15 Chapters to deeply display the global GERD market.
Chapter 1, to describe GERD Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of GERD, with sales, revenue, and price of GERD, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of GERD, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, GERD market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe GERD sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 GERD Introduction
1.2 Market Analysis by Type
1.2.1 Proton Pumps Inhibitors
1.2.2 H2 Receptor Antagonists
1.2.3 Antacids
1.2.4 Prokinetics
1.2.5 CAM
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacy
1.3.2 Drug Stores
1.3.3 General Stores
1.3.4 Supermarkets
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 GERD Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca GERD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai
2.2.1 Business Overview
2.2.2 GERD Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai GERD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 GERD Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline GERD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 GERD Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson GERD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Takeda
2.5.1 Business Overview
2.5.2 GERD Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Takeda GERD Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global GERD Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global GERD Sales and Market Share by Manufacturer (2016-2017)
3.2 Global GERD Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 GERD Manufacturer Market Share in 2017
3.3.2 Top 6 GERD Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global GERD Market Analysis by Regions
4.1 Global GERD Sales, Revenue and Market Share by Regions
4.1.1 Global GERD Sales and Market Share by Regions (2013-2018)
4.1.2 Global GERD Revenue and Market Share by Regions (2013-2018)
4.2 North America GERD Sales and Growth Rate (2013-2018)
4.3 Europe GERD Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific GERD Sales and Growth Rate (2013-2018)
4.5 South America GERD Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa GERD Sales and Growth Rate (2013-2018)
5 North America GERD by Countries
5.1 North America GERD Sales, Revenue and Market Share by Countries
5.1.1 North America GERD Sales and Market Share by Countries (2013-2018)
5.1.2 North America GERD Revenue and Market Share by Countries (2013-2018)
5.2 United States GERD Sales and Growth Rate (2013-2018)
5.3 Canada GERD Sales and Growth Rate (2013-2018)
5.4 Mexico GERD Sales and Growth Rate (2013-2018)
6 Europe GERD by Countries
6.1 Europe GERD Sales, Revenue and Market Share by Countries
6.1.1 Europe GERD Sales and Market Share by Countries (2013-2018)
6.1.2 Europe GERD Revenue and Market Share by Countries (2013-2018)
6.2 Germany GERD Sales and Growth Rate (2013-2018)
6.3 UK GERD Sales and Growth Rate (2013-2018)
6.4 France GERD Sales and Growth Rate (2013-2018)
6.5 Russia GERD Sales and Growth Rate (2013-2018)
6.6 Italy GERD Sales and Growth Rate (2013-2018)
7 Asia-Pacific GERD by Countries
7.1 Asia-Pacific GERD Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific GERD Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific GERD Revenue and Market Share by Countries (2013-2018)
7.2 China GERD Sales and Growth Rate (2013-2018)
7.3 Japan GERD Sales and Growth Rate (2013-2018)
7.4 Korea GERD Sales and Growth Rate (2013-2018)
7.5 India GERD Sales and Growth Rate (2013-2018)
7.6 Southeast Asia GERD Sales and Growth Rate (2013-2018)
8 South America GERD by Countries
8.1 South America GERD Sales, Revenue and Market Share by Countries
8.1.1 South America GERD Sales and Market Share by Countries (2013-2018)
8.1.2 South America GERD Revenue and Market Share by Countries (2013-2018)
8.2 Brazil GERD Sales and Growth Rate (2013-2018)
8.3 Argentina GERD Sales and Growth Rate (2013-2018)
8.4 Colombia GERD Sales and Growth Rate (2013-2018)
9 Middle East and Africa GERD by Countries
9.1 Middle East and Africa GERD Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa GERD Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa GERD Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia GERD Sales and Growth Rate (2013-2018)
9.3 UAE GERD Sales and Growth Rate (2013-2018)
9.4 Egypt GERD Sales and Growth Rate (2013-2018)
9.5 Nigeria GERD Sales and Growth Rate (2013-2018)
9.6 South Africa GERD Sales and Growth Rate (2013-2018)
10 Global GERD Market Segment by Type
10.1 Global GERD Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global GERD Sales and Market Share by Type (2013-2018)
10.1.2 Global GERD Revenue and Market Share by Type (2013-2018)
10.2 Proton Pumps Inhibitors Sales Growth and Price
10.2.1 Global Proton Pumps Inhibitors Sales Growth (2013-2018)
10.2.2 Global Proton Pumps Inhibitors Price (2013-2018)
10.3 H2 Receptor Antagonists Sales Growth and Price
10.3.1 Global H2 Receptor Antagonists Sales Growth (2013-2018)
10.3.2 Global H2 Receptor Antagonists Price (2013-2018)
10.4 Antacids Sales Growth and Price
10.4.1 Global Antacids Sales Growth (2013-2018)
10.4.2 Global Antacids Price (2013-2018)
10.5 Prokinetics Sales Growth and Price
10.5.1 Global Prokinetics Sales Growth (2013-2018)
10.5.2 Global Prokinetics Price (2013-2018)
10.6 CAM Sales Growth and Price
10.6.1 Global CAM Sales Growth (2013-2018)
10.6.2 Global CAM Price (2013-2018)
11 Global GERD Market Segment by Application
11.1 Global GERD Sales Market Share by Application (2013-2018)
11.2 Hospital Pharmacy Sales Growth (2013-2018)
11.3 Drug Stores Sales Growth (2013-2018)
11.4 General Stores Sales Growth (2013-2018)
11.5 Supermarkets Sales Growth (2013-2018)
12 GERD Market Forecast (2018-2023)
12.1 Global GERD Sales, Revenue and Growth Rate (2018-2023)
12.2 GERD Market Forecast by Regions (2018-2023)
12.2.1 North America GERD Market Forecast (2018-2023)
12.2.2 Europe GERD Market Forecast (2018-2023)
12.2.3 Asia-Pacific GERD Market Forecast (2018-2023)
12.2.4 South America GERD Market Forecast (2018-2023)
12.2.5 Middle East and Africa GERD Market Forecast (2018-2023)
12.3 GERD Market Forecast by Type (2018-2023)
12.3.1 Global GERD Sales Forecast by Type (2018-2023)
12.3.2 Global GERD Market Share Forecast by Type (2018-2023)
12.4 GERD Market Forecast by Application (2018-2023)
12.4.1 Global GERD Sales Forecast by Application (2018-2023)
12.4.2 Global GERD Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure GERD Picture
Table Product Specifications of GERD
Figure Global Sales Market Share of GERD by Types in 2017
Table GERD Types for Major Manufacturers
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
